CSIMarket
 


Cryoport inc   (CYRX)
Other Ticker:  
 

Cumulative Cryoport Inc 's Total Debt to Equity for Trailing Twelve Months Period

CYRX's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth


Select the Comparisons : Select the Ratio:

CYRX Total Debt to Equity for Trailing Twelve Months Period

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Growth -12.02 % -3.27 % -4.25 % -8.03 % -13.4 %
Y / Y Total Debt Growth -6.65 % -7.14 % 0.37 % 0.47 % 0.46 %
Total Debt to Equity for Trailing Twelve Months Period 0.74 0.73 0.74 0.73 0.71
Total Ranking # 1199 # 1919 # 2011 # 2072 # 2363
Seq. Equity Growth -9.02 % -1.24 % -2.9 % 0.84 % 0.02 %
Seq. Total Debt Growth 0.45 % -7.36 % 0.15 % 0.16 % -0.08 %


Total Debt to Equity for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2023
On the trailing twelve months basis Due to net new borrowings of 0.45%, Total Debt to Equity for Trailing Twelve Months Period improved to 0.74, a new company high.
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 49 other companies have achieved lower Total Debt to Equity for Trailing Twelve Months Period than Cryoport Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Debt to Equity Ratio?
CYRX Charts and Quotes
Total Debt to Equity CYRX in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 50
Sector # 150
S&P 500 # 1233


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
0.74 0.37 0.04
(Dec 31 2023)   (Dec 31 2015)




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Total Debt to Equity for Trailing Twelve Months Period
Trevena inc   1.93 
Mallinckrodt Plc  1.87 
Ascendis Pharma A  1.83 
Eli Lilly And Company  1.82 
Clene Inc   1.79 
Ocular Therapeutix Inc   1.79 
Phibro Animal Health Corporation  1.77 
Jazz Pharmaceuticals Plc  1.68 
Arcutis Biotherapeutics Inc   1.65 
Zoetis Inc   1.46 
Ionis Pharmaceuticals Inc  1.40 
G1 Therapeutics Inc   1.34 
Landec Corporation  1.33 
Bristol myers Squibb Company  1.27 
Vbi Vaccines Inc  1.15 
Emergent Biosolutions Inc   1.15 
Catalent Inc   1.15 
Corbus Pharmaceuticals Holdings Inc   1.13 
Tempest Therapeutics Inc   1.12 
Durect Corp  1.12 
Tg Therapeutics Inc   1.06 
Scynexis Inc   1.06 
Spectrum Pharmaceuticals Inc   1.05 
Chembio Diagnostics Inc   1.04 
Journey Medical Corporation  1.02 
Viatris Inc   0.89 
Aptinyx Inc   0.88 
Elanco Animal Health Inc  0.87 
Ibio inc   0.86 
Axsome Therapeutics Inc   0.85 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com